Home › Pulmonary Hypertension › Nebraska › Omaha
Pulmonary Hypertension clinical trials in Omaha, NE
4 studies for Pulmonary Hypertension are looking for participants at sites in and around Omaha (within about 30 miles). Open a study to see who can join and how to contact the study team.
Study of REGN13335 in Adult Participants With Pulmonary Arterial Hypertension (PAH)
RecruitingPhase 2
- University of Nebraska Medical Center - 2365, Omaha
Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
Recruiting
- CHI Health Creighton University Medical Center - Bergan Mercy, Omaha
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
Recruiting
- University of Nebraska Medical Center, Omaha
Breathe Easier With Tadalafil Therapy for Dyspnea in COPD-PH
RecruitingPhase 2
- Omaha VA Nebraska-Western Iowa Health Care System, Omaha, NE, Omaha
About Pulmonary Hypertension
Pulmonary hypertension (PH) is high blood pressure in the arteries to your lungs. It makes your heart work harder, which can lead to heart failure.
More about Pulmonary Hypertension on MedlinePlus
Pulmonary Hypertension trials in other cities
- Philadelphia, PA10 studies
- Aurora, CO9 studies
- Cincinnati, OH8 studies
- Phoenix, AZ8 studies
- Indianapolis, IN8 studies
- Kansas City, KS8 studies
- New York City, NY7 studies
- Bend, OR7 studies
- Rochester, MN7 studies
- Houston, TX7 studies
- Charleston, SC7 studies
- Boston, MA7 studies
Other studies in Omaha
- Prostate Cancer28 studies
- Non-Small Cell Lung Cancer25 studies
- Breast Cancer23 studies
- Cancer (all types)19 studies
- Colorectal Cancer19 studies
- Multiple Myeloma16 studies
- Ovarian Cancer15 studies
- Non-Hodgkin Lymphoma14 studies
- Metastatic Cancer14 studies
- Pancreatic Cancer14 studies
- Heart Failure13 studies
- Lung Cancer13 studies
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.